Financhill
Back

CRISPR Therapeutics AG Vs. Verve Therapeutics Industry Stock Comparison

Buy
66

CRSP
CRISPR Therapeutics AG

Last Price:
56.19
Seasonality Move:
18.28%
Sell
12

VERV
Verve Therapeutics

Last Price:
5.97
Seasonality Move:
59.44%
Buy
66
CRISPR Therapeutics AG (CRSP) is a Buy

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.22. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
12
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $5.98. The Score for VERV is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.22
    The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $5.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 47.02 Sell
Chaikin Money Flow: 885602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.68 - 56.9) Buy
Bollinger Bands (100): (56.93 - 76.01) Sell

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 32.59 Sell
Chaikin Money Flow: -1388934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.05 - 6.77) Sell
Bollinger Bands (100): (7.83 - 14.47) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.78 Buy
20-day SMA: 54.94 Buy
50-day SMA: 62.33 Sell
200-day SMA: 59.32 Sell
8-day EMA: 55.47 Buy
20-day EMA: 56.17 Buy
50-day EMA: 60.58 Sell
200-day EMA: 61.45 Sell

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.19 Sell
20-day SMA: 6.28 Sell
50-day SMA: 9.03 Sell
200-day SMA: 12.08 Sell
8-day EMA: 6.2 Sell
20-day EMA: 6.6 Sell
50-day EMA: 8.4 Sell
200-day EMA: 12.35 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):